Showing results (1131-1140 of 1,171) with videos related to

Sort By:
Pageof 118
Molecular Genetics and Metabolism|July 3, 2026
Accessibility and harmonization of biochemical tests for diagnosis and monitoring of Porphyrias in the United States: Recommendations by members of the American Porphyrias Expert Collaborative (APEX)Karl E Anderson, Robert J Desnick, Herbert L Bonkovsky, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 23, 2010
Melanoma risk factors, perceived threat and intentional tanning: an international online surveyRichard Bränström, Yu-Mei Chang, Nadine Kasparian, et al.
Nature Communications|December 8, 2018
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinomaHanyong Sun, Weiqin Yang, Yuan Tian, et al.
JAMA Cardiology|April 7, 2017
Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort StudyMatthew S Freiberg, Chung-Chou H Chang, Melissa Skanderson, et al.
The New England Journal of Medicine|May 8, 2024
Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic PurpuraPavan K Bendapudi, Brody H Foy, Sarah B Mueller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2020
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO GuidelineJohn D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccinesAmin Addetia, Alexandra Schäfer, Kaitlin Sprouse, et al.
Immunity|August 17, 2022
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responsesBrandon McLeod, Moustafa T Mabrouk, Kazutoyo Miura, et al.
Lupus|October 7, 2022
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, et al.
Nature Biotechnology|September 25, 2023
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responsesMenglin Wang, Benoit Rousseau, Kunyu Qiu, et al.
Pageof 118